Gilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid...
- EXEC
- 14/03/2024
Gilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid Disorder
READ MOREGilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid Disorder
READ MOREAffidea Expands in Northern Switzerland with Two Acquisitions
READ MOREMEDICA & COMPANED 2024: Innovations for Healthcare - International, Diverse; 6,000+ Exhibitors
READ MOREEx-HSE Chief Who Received Nearly €400,000 Exit Package Now Working with NI Health Service
READ MOREAffidea Enters into an Agreement to Acquire MedEuropa Romania
READ MOREAffidea Successfully Reprices Debt, Secures €200M Credit for Growth
READ MOREENPICOM and Erasmus University Medical Centre Partner to Discover Cancer Nanobodies
READ MOREAffidea Group Expands in Spain and Italy with 3 Key Acquisitions
READ MOREMedscape Global Unveils Programmatic Engagement, Setting New Standard for HCPs in UK, EU & Canada
READ MOREPhilips Achieves Robust FY Results; FDA Consent Decree for Respironics in US
READ MORE